Skip to main content

Table 1 Demographic and baseline characteristics of patients with HF hospitalization

From: Recurrent heart failure hospitalizations increase the risk of mortality in heart failure patients with atrial fibrillation and type 2 diabetes mellitus in the United Kingdom: a retrospective analysis of Clinical Practice Research Datalink database

Characteristics

T2DM

AF

Overall

Recurrent HF Hospitalizations

Overall

Recurrent HF Hospitalizations

None

 ≥ 1

None

≥ 1

N

2344

1573

771

4585

3294

1291

Age at index (Mean [SD])

76.4 (10.32)

76.7 (10.4)

75.8 (10.0)

79.6 (10.3)

78.8 (10.3)

79.9 (10.4)

Gender, Male (%)

59.1

58.7

59.9

54.2

55.2

53.9

Any CRT devices prior to index (%)

15.4

14#

18.2#

16.9

15.3#

20.8#

Follow-up time (Patient years)

4268.5

2514.2

1753.3

7845.6

5142

2703.6

Smoking status (%)

      

Current smoker

11.9

12.5

10.5

9.8

9.8

9.8

Never smoker

41.5

41.0

42.4

41.4

41.2

41.9

Former smoker

44.8

44.6

45.1

41.6

41.3

42.2

Missing/unknown

1.9

1.9

1.9

7.3

7.7

6.1

BMI (Mean [SD])*

30.9 (7.0)

30.8 (7.1)

31.1(6.9)

28.5(6.8)

28.3(6.9)

28.9(6.5)

Underweight: < 18.5 kg/m2 (%)

0.9

0.9

1.0

1.5

1.6

1.1

Normal weight: >  = 18.5 and < 25 kg/m2 (%)

14.6

15.1

13.6

16.9

16.8

17.1

Overweight: >  = 25 and < 30 kg/m2 (%)

23

23

23

17.2

16.6

18.8

Obese: >  = 30 kg/m2 (%)

40.7

39.7

42.7

20.2

19.1

23.1

Missing/Unknown (%)

20.8

21.4

19.7

44.2

45.8

40.0

Comorbidities (%)*

      

AF

49.9

49.1

51.5

100

100

100

Anemia

25.2

24.5

26.6

20.2

19.4#

22.2#

Angina pectoris

28.7

27.3

31.7

23.4

22.8

25.1

Dyslipidemia

30.5

30.3

30.9

19.8

18.8#

22.3#

Hypertension

76.5

76.0

77.4

68.0

67.0#

70.6#

Oedema

23.9

24.9

21.9

23.3

24.0

21.5

Chronic pulmonary disorder

31.5

31.7

31.1

27.5

26.9

28.9

Diabetes

100

100

100

26.2

24.1#

31.3#

Myocardial infarction

21.2

20.9

21.9

16.4

16.2

16.8

Renal disease

38.1

37.5

39.4

30.1

29.7

31.2

Pneumonia

16.3

16.5

16.1

17.6

18.4#

15.7#

Ischaemic heart disease

58.2

57.1

60.3

47.3

46.2

50.1

Any concomitant medications at index (%)

85.7

84.8

87.4

82.5

81.3

85.6

ACEi

53.1

53.2

52.9

47.6

46.5

50.4

ARB

23.7

22.5#

26.2#

19.0

17.9#

21.7#

ACEi/ARB

74.2

73.1

76.4

65.0

63.1#

70.1#

Beta-blockers

53.5

52.4

55.6

55.4

54.7

57.2

MRA

19.2

17.3#

23#

18.8

17.5#

22.3#

eGFR (Mean [SD])*

61.5(25.9)

62(25.3)

60.4 (25)

63.6 (24.2)

64.2(24.2) #

62.2 (24.0)

eGFR >  = 60 ml/min/1.73 m2

47.7

48.6

45.9

49.1

50.1

46.9

eGFR < 60 ml/min/1.73 m2

47.8

46.5

50.3

40.7

39.3

44.4

Missing/unknown

4.9

4.8

3.8

10.1

10.7

8.8

  1. *Within 1 year prior to index date; #significant differences between pts with and or without recurrent HF
  2. ACEi angiotensin-converting enzyme inhibitor, AF atrial fibrillation, ARB angiotensin receptor blocker; CRT cardiac resynchronization therapy, CV cardiovascular, eGFR estimated glomerular filtration rate, HF heart failure, MRA mineralocorticoid receptor antagonist T2DM type 2 diabetes mellitus